Effectiveness of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide in people with HIV with very high viral load (≥500 000 copies/mL) [0.03%]
恩曲他滨/富马酸替诺福韦二吡美.drive对拉米夫定和 bictegravir/emtricitabine/tenofovir alafenamide治疗HIV-1患者高病毒载量(≥500 000 copies/mL)的效果
Juan Martin-Torres,Roser Navarro-Soler,Judit Iglesias-Franco et al.
Juan Martin-Torres et al.
Objectives: To compare the effectiveness of dolutegravir/lamivudine (DTG/3TC) versus bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) at Week 48 in treatment-naive adults with high baseline viral loads (≥500...
Comparative Study
The Journal of antimicrobial chemotherapy. 2026 Aug 4;81(9):dkag285. DOI:10.1093/jac/dkag285 2026
Pharmacokinetics of abacavir and lamivudine in infants living with HIV with and without rifampicin co-treatment [0.03%]
接受和未接受利福平联合治疗的HIV感染婴儿体内阿巴卡韦和拉米夫定的药代动力学特征研究
Laize Sílvia Dos Anjos Botas Beca,Vivian Mumbiro,Mutsa Bwakura et al.
Laize Sílvia Dos Anjos Botas Beca et al.
Background: Lamivudine and abacavir are key components of first-line paediatric antiretroviral therapy (ART). Rifampicin is part of drug-sensitive TB treatment in children. Rifampicin induces UDP-glucuronosyltransferases ...
Antimicrobial-loaded PMMA bone cement: time for good practice recommendations [0.03%]
抗菌性PMMA骨水泥:实践建议的最佳时机
Tariq Azamgarhi,Herbert Gbejuade,Ryan A Hamilton et al.
Tariq Azamgarhi et al.
Antimicrobial-loaded PMMA bone cement has been used since the 1970s as both a fixation material and a local antimicrobial reservoir. Its clinical roles differ between prophylaxis in primary arthroplasty and treatment of established infectio...
Towards standardized antifungal susceptibility testing for Sporothrix brasiliensis [0.03%]
巴西副球孢子菌的抗真菌药物敏感性标准化检测初探
Bram Spruijtenburg,Carolina Melchior Do Prado,Mariana Rodrigues Trápaga et al.
Bram Spruijtenburg et al.
Sporotrichosis caused by Sporothrix brasiliensis is increasingly reported in South America. Infections in humans are mostly due to zoonotic transmission by cats. For both hosts, itraconazole is the drug of choice despite long treatment dura...
Performance of plasma separation cards for HIV drug-resistance genotyping in a resource-limited setting: comparison with plasma samples [0.03%]
富集地区HIV耐药基因分型中塑料芯片与血浆样本的比较研究
Thang Hong Pham,Hanh Thi Hong Ngo,Tram Thi Phuong Pham et al.
Thang Hong Pham et al.
Background: HIV drug resistance (HIVDR) threatens the effectiveness of antiretroviral therapy (ART) programmes in low- and middle-income countries. The Cobas Plasma Separation Card (PSC) is a recently developed specimen c...
Comparative Study
The Journal of antimicrobial chemotherapy. 2026 Aug 4;81(9):dkag279. DOI:10.1093/jac/dkag279 2026
Antibiotic consumption in HIV and PrEP populations with and without sexually transmitted infections: a population-based observational study [0.03%]
一项基于人口的观察性研究:艾滋病和暴露前预防人群中是否有性传播疾病对抗生素消耗量的影响
Adrián Valls-Carbó,Raquel Siguín,Alberto Delgado-Iribarren et al.
Adrián Valls-Carbó et al.
Background: Antimicrobial resistance is driven by antibiotic exposure. People living with HIV (PLWH) and PrEP users face high STI rates, but the magnitude of cumulative antibiotic exposure in these populations compared wi...
Observational Study
The Journal of antimicrobial chemotherapy. 2026 Aug 4;81(9):dkag228. DOI:10.1093/jac/dkag228 2026
Prospective evaluation of imipenem trough concentrations and clinical outcomes in critically ill patients [0.03%]
重症患者美罗培南谷浓度与临床结局的相关性研究
Mia Madeleine Lidén,Filippo Boroli,Elodie Von Dach et al.
Mia Madeleine Lidén et al.
Background: Imipenem is a broad-spectrum antibiotic commonly used in critically ill patients, whose pharmacokinetic profile can be highly variable. While imipenem therapeutic drug monitoring (TDM) is being adopted increas...
Observational Study
The Journal of antimicrobial chemotherapy. 2026 Aug 4;81(9):dkag242. DOI:10.1093/jac/dkag242 2026
Liposomal amphotericin B retrospective multicentre study on mycosis prophylaxis (L-AmB_RUSCO): tolerability and safety of extended-dosing primary antifungal prophylaxis in children with newly diagnosed acute myeloid leukaemia [0.03%]
儿童粒细胞缺乏伴发热时延长给药的主要抗真菌预防治疗的耐受性和安全性:利泊达前瞻性多中心研究(L-AmB_RUSCO)
Erica Ricci,Alessio Mesini,Marcello Mariani et al.
Erica Ricci et al.
Objectives: To evaluate the tolerability and safety of extended-dosing liposomal amphotericin B (LAmB) as primary antifungal prophylaxis against invasive fungal disease (IFD) in children receiving chemotherapy for newly d...
Observational Study
The Journal of antimicrobial chemotherapy. 2026 Aug 4;81(9):dkag289. DOI:10.1093/jac/dkag289 2026
Characterization of the intrinsic AmpC β-lactamase of Escherichia marmotae and its impact on decreased susceptibility to cefiderocol and resistance to broad-spectrum cephalosporins [0.03%]
鼠疫耶尔森菌固有AmpCβ-内酰胺酶的表征及其对头孢地利低度敏感性及广谱头孢菌素耐药性的影响
Samanta Freire,Sandra Martinez Alvarez,Jacqueline Findlay et al.
Samanta Freire et al.
Objectives: We aimed to characterize the intrinsic AmpC β-lactamase (EMC-2) from an Escherichia marmotae clinical isolate recovered from a bloodstream infection, exhibiting resistance to broad-spectrum cephalosporins. ...
Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment [0.03%]
高风险血液病患者左氧氟沙星预防失败的危险因素:一项关于耐药定植和药物代谢动力学/药物效应动力学达标率的研究
Cemre Boşnak,Gökhan Metan,Pınar Zarakolu et al.
Cemre Boşnak et al.
Objectives: To evaluate the clinical and microbiological factors associated with the failure of levofloxacin prophylaxis in high-risk haematology patients, with a particular focus on the attainment of the pharmacokinetic/...